Evidence map›Paper›PMID 40612382›Full record

ArticleFrontiers in artificial intelligence2025

Biologically inspired hybrid model for Alzheimer's disease classification using structural MRI in the ADNI dataset.

Houmem Slimi, Imen Cherif, Sabeur Abid, Mounir Sayadi

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Houmem SlimiResearch Laboratory SIME, ENSIT, University of Tunis, Tunis, Tunisia.
Imen CherifResearch Laboratory SIME, ENSIT, University of Tunis, Tunis, Tunisia.
Sabeur AbidResearch Laboratory SIME, ENSIT, University of Tunis, Tunis, Tunisia.
Mounir SayadiResearch Laboratory SIME, ENSIT, University of Tunis, Tunis, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and structural brain alterations such as cortical atrophy and hippocampal degeneration. Early diagnosis remains challenging due to subtle neuroanatomical changes in early stages. This study proposes a hybrid convolutional neural network-spiking neural network (CNN-SNN) architecture to classify AD stages using structural MRI (sMRI) data from the Alzheimer's Disease Neuroimaging Initiative (ADNI). The model synergizes CNNs for hierarchical spatial feature extraction and SNNs for biologically inspired temporal dynamics processing. The CNN component processes image slices through convolutional layers, batch normalization, and dropout, while the SNN employs leaky integrate-and-fire (LIF) neurons across 25 time steps to simulate temporal progression of neurodegeneration-even with static sMRI inputs. Trained on a three-class task [AD, mild cognitive impairment (MCI), and cognitively normal (CN) subjects], the hybrid network optimizes mean squared error (MSE) loss with L2 regularization and Adam, incorporating early stopping to enhance generalization. Evaluation on ADNI data demonstrates robust performance, with training/validation accuracy and loss tracked over 30 epochs. Classification metrics (precision, recall,

Indexed as

Alzheimer’s disease (AD)convolution neural networks (CNN)cross-validationMRI imagesspiking neural networks (SNN)

Identifiers

PMID40612382
PMCPMC12222329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.